- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +10 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Stanford Cancer Center Stanford, California, United States
- Weill Cornell Medical College New York, United States
- Levine Cancer Institute - Blythe Charlotte, North Carolina, United States
Clinical trial condition
Lymphoma, Large B-Cell, Diffuse
Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.
1,249 public trials
217 recruiting studies
Lymphoma, Large B-Cell, Diffuse trial results
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
- Locations
-
- Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
- Providence Cancer Center Anchorage, Alaska, United States
- Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
- Mountain States Tumor Institute at St. Luke's Regional Medical Center Boise, Idaho, United States
NCT01481272
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Dolnośląskie Centrum Transplantacji Komórkowych Wroclaw, Lower Silesian Voivodeship, Poland
- Instytut Hematologii i Transfuzjologii Warsaw, Masovian Voivodeship, Poland
- Centrum Onkologii - Istytut im. M.Sklodowskiej-Curie Warsaw, Masovian Voivodeship, Poland
- Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im. ks. Bronisława Markiewicza Brzozów, Podkarpackie Voivodeship, Poland
NCT05169203
- Conditions
- Diffuse Large B Cell Lymphoma, Diffuse Large B-Cell Lymphoma Cell of Origin, Diffuse Large B-cell Lymphoma Recurrent, +11 more
- Locations
-
Not specified
NCT03104478
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- CHU Caen Caen, France
- Hopital Henri Mondor Créteil, France
- CHU Le Bocage Dijon, France
- CH Départemental La Roche-sur-Yon, France
- Conditions
- DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-cell Lymphoma, Disease Attributes, +17 more
- Locations
-
- Arizona Clinical Research Center Tucson, Arizona, United States
- Arizona Oncology Associates Tucson, Arizona, United States
- Highlands Oncology Group Bentonville, Arkansas, United States
- Highlands Oncology Group Fayetteville, Arkansas, United States
Completed
Rituximab Plus CHOP With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
NCT00599170
- Conditions
- Diffuse, Large B-Cell, Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT05113576
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Department of Nuclear Medicine and PET/CT Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT04317313
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT04697160
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- MorphoSys Research Site Scottsdale, Arizona, United States
- MorphoSys Research Site Clovis, California, United States
- MorphoSys Research Site Los Angeles, California, United States
- MorphoSys Research Site Orange, California, United States